SynopsisAntimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial .....
SynopsisAntibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans a.....
SynopsisProbiotics are the friendliest types of bacteria and take up residence in our body from the day we are born. Probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery .....
SynopsisThe global Electric Surgical Drills market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global market for medical devices is.....
SynopsisCompound clotrimazole is a broad spectrum anti-fungal agent, which is used for the treatment of dermal infections. The ointment is majorly used for the topical treatment of candidiasis and tinea versicolor pityriasis versicolor. In addition, it is used in the .....
SynopsisGuided tissue regeneration (GTR) are dental surgical procedures that use barrier membranes to direct the growth of new bone and gingival tissue at sites with insufficient volumes or dimensions of bone or gingiva for proper function, esthetics or prosthetic res.....
SynopsisAnimal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have bee.....
Synopsis Global Chronic Leg Pain Therapy Solutions market is projected to reach US$ 1138.3 million in 2029, increasing from US$ 821 million in 2022, with the CAGR of 5.3% during the period of 2023 to 2029. Influencing issues, such as economy environments.....
SynopsisThe global Epidermolysis Bullosa Therapeutics market size is expected to reach US$ 2268.2 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Epidermolysis Bullosa Therapeutics in various.....
SynopsisThe global COVID-19 Sample Transport Temperature Bioindicator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for COVID-19 Sample.....
